GlaxoSmithKline (Spain)

About

In recent decades, authors affiliated with GlaxoSmithKline (Spain) have published 758 papers, which have received a total of 20.0k indexed citations. Scholars at this organization have produced 185 papers in Epidemiology, 176 papers in Molecular Biology and 161 papers in Public Health, Environmental and Occupational Health on the topics of Malaria Research and Control (94 papers), Tuberculosis Research and Epidemiology (67 papers) and Asthma and respiratory diseases (65 papers). Their work is cited by papers focused on Molecular Biology (5.0k citations), Epidemiology (4.9k citations) and Infectious Diseases (3.6k citations). Authors at GlaxoSmithKline (Spain) collaborate with scholars in Spain, United States and United Kingdom and have published in prestigious journals including Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences. Some of GlaxoSmithKline (Spain)'s most productive authors include Gonzalo Colmenarejo, Karen K. Biron, Terry Kenakin, Francisco‐Javier Gamo, César Garcı́a-Rey, Marc Miravitlles, Francisco García‐Río, Julio Ancochea, Joan B. Soriano and Lluís Ballell.

In The Last Decade

GlaxoSmithKline (Spain)

735 papers receiving 20.0k citations

Fields of papers published by authors at GlaxoSmithKline (Spain)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with GlaxoSmithKline (Spain) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with GlaxoSmithKline (Spain) at the time of their publication.

Countries citing scholars working at GlaxoSmithKline (Spain)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at GlaxoSmithKline (Spain). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at GlaxoSmithKline (Spain) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GlaxoSmithKline (Spain) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2026